Peter Symonds
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 14
- Galectins and Cancer Biology 2
-
- RNA Interference and Gene Delivery 6
- vaccines and immunoinformatics approaches 5
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- J. Clifford Murray (7 shared papers)A. Christy Hunter (2 shared papers)Grażyna Dębska (2 shared papers)S. Moein Moghimi (2 shared papers)Adam Szewczyk (2 shared papers)Victoria A. Brentville (15 shared papers)Lindy G. Durrant (15 shared papers)Samantha Paston (4 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)OncoImmunology (3 papers)Molecular Therapy (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomJapanPoland
In The Last Decade
Peter Symonds
23 papers receiving 1.5k citations
Peter Symonds's Hit Papers
Peers
Comparison fields: 5 of 95
- Biomaterials 253
- Immunology 401
- Molecular Biology 1.1k
- Genetics 304
- Oncology 228
Countries citing papers authored by Peter Symonds
This map shows the geographic impact of Peter Symonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Symonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Symonds more than expected).
Fields of papers citing papers by Peter Symonds
This network shows the impact of papers produced by Peter Symonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Symonds. The network helps show where Peter Symonds may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Symonds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Hit paper breakdown → | 2005 | 930 |
| 2 | 2021 | 139 | |
| 3 | 2005 | 99 | |
| 4 | 2016 | 80 | |
| 5 | 2020 | 44 | |
| 6 | 2017 | 40 | |
| 7 | 2016 | 35 | |
| 8 | 2006 | 35 | |
| 9 | 2004 | 30 | |
| 10 | 2004 | 29 | |
| 11 | 2019 | 17 | |
| 12 | 2022 | 15 | |
| 13 | 2016 | 14 | |
| 14 | 2006 | 13 | |
| 15 | 2007 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 10 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2024 | 3 |
About Peter Symonds
Peter Symonds is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Infectious Diseases, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), RNA Interference and Gene Delivery (6 papers), vaccines and immunoinformatics approaches (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Galectins and Cancer Biology (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Biomaterials (253 citations), Immunology (401 citations), Molecular Biology (1.1k citations), Genetics (304 citations) and Oncology (228 citations). Peter Symonds has collaborated with scholars based in United Kingdom, Japan and Poland. Frequent co-authors include J. Clifford Murray, A. Christy Hunter, Grażyna Dębska, S. Moein Moghimi, Adam Szewczyk, Victoria A. Brentville, Lindy G. Durrant, Samantha Paston, Rachael L. Metheringham and Katherine Cook. Their work appears in journals such as Frontiers in Immunology, Journal for ImmunoTherapy of Cancer, OncoImmunology, Molecular Therapy and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.